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IT has been shown that  Bothrops  jararaca venom
(BjV)  induces  a  significant  leukocyte  accumulation,
mainly  neutrophils,  at  the  local  of  tissue  damage.
Therefore, the role of the adhesion molecules inter-
cellular  adhesion  molecule-1  (ICAM-1),  LECAM-1,
CD18, leukocyte function-associated antigen–1 (LFA-
1) and platelet endothelial cell adhesion molecule-1
(PECAM-1) on the BjV-induced neutrophil accumula-
tion and the correlation with release of LTB4, TXA2,
tumor  necrosis factor-a,  interleukin (IL)-1  and IL-6
have been investigated. Anti-mouse LECAM-1, LFA-1,
ICAM-1 and PECAM-1 monoclonal antibody injection
resulted in a reduction of 42%, 80%, 66% and 67%,
respectively, of neutrophil accumulation induced by
BjV  (250 m g/kg,  intraperitoneal)  injection  in  male
mice compared with isotype-matched control injec-
ted animals. The anti-mouse CD18 monoclonal anti-
body  had  no  significant  effect  on  venom-induced
neutrophil  accumulation.  Concentrations  of  LTB4,
TXA2, IL-6 and TNF-a were significant increased in the
peritoneal exudates of animals injected with venom,
whereas  no  increment  in  IL-1  was  detected.  This
results  suggest  that  ICAM-1,  LECAM-1,  LFA-1  and
PECAM-1,  but  not  CD18,  adhesion  molecules  are
involved in the recruitment of neutrophils into the
inflammatory site induced by BjV. This is the first in
vivo evidence that snake venom is able to up-regulate
the expression of adhesion molecules by both leuko-
cytes and endothelial cells. This venom effect may be
indirect, probably through the release of the inflam-
matory mediators evidenced in the present study.
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Introduction
The snake Bothropos jararaca is responsible for most
snakebite  accidents  in  Brazil.  Its  venom  induces
severe  pathophysiological  effects  characterized  by
local tissue damage, with hemorrhage, pain, myone-
crosis and  inflammation.1–3 Several  studies  demon-
strate  that  Bothrops venoms  induce  a  significant
leukocyte  accumulation  at  the  site  of  inflamma-
tion.4–6 However,  the  mechanisms  involved  in  this
event have not been elucidated. Leukocyte accumula-
tion  in  inflamed  tissue  results  from  generation  of
chemotactic factors as well as adhesive interactions
between leukocytes and endhotelial cells within the
microcirculation.7
Leukocyte recruitment  into  inflammatory  sites  is
known to be a multi-step process, which is charac-
terized  by  an  initial  transient  contact  with  the
endothelium, or  rolling,  followed  by  firm  adhesion
and transmigration.8,9 The initial phase of the adhe-
sion  cascade,  neutrophil  rolling,  is  mediated  by
members  of  the  selectin  family  (L-selectin  on  neu-
trophils, and P-selectin and E-selectin on endothelial
cells). Next, intercellular adhesion molecule-1 (ICAM-
1)  (CD54),  which  belongs  to  the  immunoglobulin
superfamily,  binds  to  leukocyte  function-associated
antigen–1 (LFA-1) (CD11/CD18) on leukocytes.10This
interaction results in arrest and firm adhesion of the
neutrophil  to  the  endothelium,  and  is  required  for
transendothelial  cell  migration.11 Finally,  platelet
endothelial  cell  adhesion  molecule-1  (PECAM-1)
(CD31)  is  required  for  the  activation  of  proteases
needed  for  passage  through  endothelial  junctions
and/or the basement membrane.12,13 Each adhesion
molecules is involved in a different phase of leukocyte
emigration  through  the  endothelium,  and  the  syn-
chronization  of  their  expression  and  functions  is
crucial for recruitment of leukocytes from the blood-
stream  to  the  tissue.14 A  range  of  inflammatory
mediators  regulates  this  cascade  by  a  sequential
release.15
In  the  present  study  we  investigated  the  impor-
tance of  some  adhesion molecules  (ICAM-1,  LFA-1,
PECAM-1,  LECAM-1  and  CD18  b2-integrin)  in  the
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injection  of  B.  jararaca venom  in  mice  and  the
release of some inflammatory cytokines and eicosa-
noids.  Understanding  the  mechanisms  of  venom-
induced cell  influx  will  be  helpful  for the pharma-
cological  modulation  of  inflammatory  events
associated  with  Bothrops venom-induced  local
injury.
Materials and methods
Chemicals and reagents
Heparin was obtained from  Roche (Rio  de Janeiro,
Brazil).  Murine  capture  antibody  anti-IL-6  (clone
MP5–20F3), recombinant IL-6 and detection antibody
anti-IL-6  (clone  MP5–32C11)  were  purchased  from
Pharmingen  (CA,  USA).  Rat  monoclonal  antibodies
directed against L-selectin (anti-mouse CD62L, clone
MEL–14), ICAM-1 (anti-mouse CD54, clone 3E2), LFA-
1-a chain (anti-mouse CD11a, clone M17/4), PECAM-1
(anti-mouse  CD31,  clone  MEC  13.3),  b2-integrin  b
chain  (anti-mouse  CD18,  clone  GAME  46)  were
purchased  from  Pharmingen.  Rat  immunoglobulin
(Ig)G  anti-horse  IgG  (irrelevant  antibody)  derived
from  mouse  myeloma  (ascitic  fluid)  was  kindly
provided by Dr Irene Fernandes (Immunopathology
Laboratory,  Butantan  Institute,  S˜ ao  Paulo,  Brazil).
2,29-Azino-bis(3  ethylbenzthiazoline–6-sulfonic  acid)
ABTS  was  purchased  from  Southern  Biotechnology
Associates Inc. (AL, USA). All salts used were obtained
from Merck (Darmstadt, Germany).
Venom
Lyophilized crude  venom of  B. jararaca (BjV)  was
supplied by the Herpetology Laboratory of Butantan
Institute. The  venom  was  dissolved in  0.15M NaCl
solution and subsequently filtered through sterilizing
membranes (0.22mm pore size; Millipore Ind. Com.
Ltd, Brazil) before use.
Animals
Male Swiss mice (18–20g) were used. These animals
were  housed  in  temperature-controlled  rooms  and
received water and food ad libitum until used. These
studies were approved by the Experimental Animals
Committee  of  Butantan  Institute  (protocol  number
014/2001)  in  accordance with  the  procedures laid
down  by  the  Universities  Federation  for  Animal
Welfare.
Induction of inflammatory reaction
BjV  (250mg/kg),  dissolved  in  1ml  of  sterile  saline
was  injected  by  the  intraperitoneal  (i.p.)  route.
Control animals received 1ml of sterile saline alone.
At  selected  time  intervals,  the  animals  were  killed
under a halothane atmosphere and the inflammatory
exudate  was  withdrawn  after  washing  the  cavities
with  2ml  of  phosphate-buffered  saline  (PBS)  (pH
7.2). Aliquots of the washes were used to determine
total  cell  counts. The  remaining  volume  was  cen-
trifuged  at  500 ´ g for  6min  (at  4°C),  and  super-
natants  were  stored  at  –70°C  and  later  used  for
the  determination  of  eicosanoids  or  cytokine
concentration.
Leukocyte harvesting and counting
Leukocytes were harvested 6h after i.p. injection of
BjV or  sterile  saline by  washing peritoneal cavities
with  2ml  of  PBS  containing  heparin  (10U/ml).
Aliquots of the washes were used to determine total
cell  counts  in  a  Neubauer  chamber  after  dilution
(1:20, v/v) in Turk solution (0.2% crystal violet dye in
30% acetic acid). For differential cells counts, cyto-
spin  preparations  were  stained  with  Hema3 stain
(Biochemical Sciences Inc.). Differential cell counts
were performed by counting at least 100 cells, which
were classified as either polymorphonuclear or mono-
nuclear cells, based on conventional morphological
criteria.
Treatment with anti-adhesion molecules
Groups of mice were injected intravenously (i.v.), in
the tail vein, with antibodies against adhesion mole-
cules (1mg/kg).16 Control animals received a similar
injection of  either  saline  solution  or  an  equivalent
dose of control rat IgG monoclonal antibody (mAb
(LO-HoGa–3I),  which  recognizes  horse  IgG(T).17
After  30min,  mice  were  injected  i.p.  with  BjV
(250mg/kg), and the neutrophil influx was assessed at
6h, as already described.
Quantification of eicosanoid concentrations
Concentrations of LTB4 and TXB2 (stable metabolite
of TXA2) were measured in the peritoneal washes at
30,  60  and  240min  after  i.p.  injections  of  BjV
(250mg/kg) or sterile saline, by a specific enzymatic
immunoassay (EIA) previously described by Pradelles
et al.18 using a commercial kit (Cayman Chemicals,
MI, USA), after extraction of eicosanoids on Sep Pak
C18  columns  eluted  with  ethanol.  In  brief,  100ml
aliquots  of  each  extracted  sample  were  incubated
with the eicosanoids conjugated with acetylcholines-
terase and the specific  rabbit  antiserum, in  96-well
microtitration  plates  coated  with  anti-rabbit  IgG
mouse  monoclonal  antibody.  After  addition  of  the
substrate,  the  absorbances  of  the  samples  were
recorded at 412nm in a microplate reader, and the
concentration of the eicosanoids was estimated from
standard curves.
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Peritoneal  washes  were  collected  30,  60,  180  and
360min  after  i.p.  injection  of  BjV  (250mg/kg)  or
saline.  After  centrifugation,  the  supernatants  were
used for determination of IL-6 and IL-1a levels by a
specific  EIA,  as  described  by  Schumaker  et  al.19
Briefly, 96-well plates were coated with 50ml of the
first  capture  monoclonal  antibody  (anti-IL-6,
2.5mg/ml;  or  anti  IL-1a,  2mg/ml)  and  incubated
overnight  at  room  temperature.  Then  200ml  of
blocking buffer, containing PBS/Tween-milk 5%, were
added to the wells and the plates incubated for 2h at
room  temperature.  After  washing,  50ml  of  either
samples or standards were dispensed into each well
and the plates incubated for 2h at room temperature.
Wells  were  washed,  and  bound  IL-6  or  IL-1a was
detected  by  the  addition  of  the  biotinylated  anti-
cytokine monoclonal antibody (5mg/ml, 50ml/well).
After incubation and washing, 50ml of avidin-phos-
phatase  or  peroxidase-labeled  streptavidin  were
added, followed  by  incubation  and  addition of  the
substrate  (200ml/ml  of  p-nitrophenylphosphate  or
50ml/ml  of  o-phenyldianizidine)  for  IL-6  or  IL-1a
detection, respectively. Absorbances at 450nm were
recorded and plotted against a standard curve  pre-
pared  with  recombinant  IL-6  or  IL-1a in  order  to
determine the concentration of this cytokine.
Quantification of TNF-a concentrations
Peritoneal washes were collected 30min, and 1, 3 and
6h after i.p. injection of  BjV (250mg/kg)  or saline.
After centrifugation, the cells were used for determi-
nation of TNF-a levels by a standard assay using the
fibroblast continuous cell line L–929, as described by
Ruff and Gifford.20 Monolayers of L–929 cells grown
in RPMI–1640 medium were seeded at 3.5 ´ 104 cells
per  well  in  microtiter  plates  and  incubated  in
humidified  air  with  5%  CO2 at  37°C  for  18h.
Afterwards, 100ml  of  the samples containing 2.5 ´
104 peritoneal  cells  were  added  serially  and
0.2mg/well  of  the  anti-TNF-a was  added  for  the
determination of the assay specificity. The plates were
incubated during  4h, and actinomycin D (2mg/ml)
was then added. After  incubation for  18h at 37°C,
supernatants  were  removed  and  viable  cells  were
assessed after fixation and staining with crystal violet
(0.2% in 20% methanol). Cytotoxicity, expressed as a
percentage,  was  calculated  as  follow  (Abscontrol –
Abssample / Abscontrol) ´ 100. TNF-a levels were then
expressed as picograms per milliter, using a standard
curve prepared with recombinant TNF-a.
Statistical analysis
Means  and  SEM  of  all  data  were  obtained  and
compared  by  analysis  of  variance  followed  by  the
Tukey  test,  with  significance  probability  levels  of
p < 0.05.
Results
Effect of treatment with mAbs against
adhesion molecules on neutrophil influx
To  test  whether adhesion molecules  play  a  critical
role on BjV-induced neutrophil in vivo, the effect of
neutralizing mAbs against several adhesion molecules
was examined. Since maximal neutrophil influx was
observed  6h  after  venom  injection,3 we  evaluated
these mAbs on neutrophil accumulation at this time
point.  As  shown  in  Fig.  1,  i.v.  injection  of  saline
followed by i.p. injection of BjV (5mg/mouse) caused
accumulation of (1.3 ± 0.1) ´ 106 neutrophils at 6h.
Intravenous  administration  ofmAbs  anti-ICAM-1,
anti-LECAM-1,  anti-LFA-1  and  anti-PECAM-1
(200mg/mouse) 30min before the i.p. injection of the
BjV  significantly  reduced the  number  of  recovered
neutrophils to (0.44 ± 0.11) ´ 106, (0.75 ± 0.15) ´ 106,
(0.26  ±  0.09)  ´ 106 and  (0.43  ±  0.17)  ´ 106
neutrophils, respectively (p < 0.05,  compared with
BjV), a response that was not significantly different
from that seen after i.p. injection of saline [(0.6 ± 0.1)
´ 106 neutrophils]. In contrast, anti-CD18mAbs did
not inhibit neutrophils infiltration.
Leukocyte recruitment induced by BjV
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FIG.  1.  The  effect  of  anti-murine  adhesion  molecules  on
themAbs on the recruitment of peritoneal neutrophils after
administration of BjV. Mice were pre-treated i.v. with 1mg/kg
of the indicatedmAb, rat normal IgG or saline 30min before
i.p. injection of  BjV  (250mg/kg).  Peritoneal cells  were har-
vested  and  counted  6h  after  envenomation.  A  negative
control group of animals received an i.v. injection of saline.
Data represent the mean ± SEM of at least four mice in each
group. #p < 0.05 compared with control (saline), *p < 0.05
compared with BjV or BjV + normal rat IgG.Changes in peritoneal exudate eicosanoid and
cytokine release
To investigate the ability of of BjV to release chem-
otactic mediators  in  the  peritoneal  cavity  of  mice,
the concentrations of  LTB4 and TXA2 in the perito-
neal  fluids  of  these  animals  were  measured.  BjV
(250mg/kg)  induced  a  marked  increase  in  perito-
neal TXB2 levels between 30 and 240min. LTB4 was
significantly  increased  between  60  and  240min
(Fig. 2).
To further analyze the mechanisms of the inflamma-
tory events induced by BjV, the concentrations of IL-6,
IL-1a and TNF-a in the peritoneal fluid were meas-
ured. BjV induced a rapid elevation of IL-6 levels in
the peritoneal exudate, peaking 3h after the injection
of the venom, and returning to normal values at 6h
(Fig. 3). The peak concentration was 14.5ng/ml and
control value was 5ng/ml. No detectable levels of IL-
1a were  observed  in  the  peritoneal  exudates  col-
lected after the injection of BjV (data not shown).
The venom significantly  induced a marked incre-
ment of TNF-a levels at  all  time intervals  analyzed,
except at 3h. An early increase was observed 30min
after BjV injection, with maximum levels at 1h (580%
increment  when  compared  with  levels  in  control
mice) (Fig.4).
Discussion
Neutrophils  migrate  from  vessels  in  response  to  a
stimulus  at  the  inflammatory  site.  The  onset  of
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FIG.  2.  LTB4 and  TXB2 concentration  in  the  peritoneal
exudate after BjV injection. Groups of animals were injected
i.p. with BjV (250mg/kg) or sterile saline (control). Concentra-
tion  of  LTB4 and  TXB2 was  evaluated  by  specific  EIA  in
peritoneal washes collected 30, 60 and 240min after injec-
tion. Each bar represents the mean ± SEM from four animals.
*p < 0.05 compared with control.
FIG. 3. Release of IL-6 induced by BjV. Animals received i.p.
injection of  BjV  (250mg/kg)  or  sterile saline  (control).  The
concentrations of IL-6 in the peritoneal wash was evaluated
by enzyme immunoassay 0.5, 1, 3 and 6h  after injection.
Values represent the mean ± SEM from five or six animals.
*p < 0.01 compared with control.
FIG. 4. Release of TNF-a induced by BjV in the peritoneal
cavity  of  mice.  Animals  were  injected  i.p.  with  BjV
(250mg/kg) or sterile saline (control). Concentrations of TNF-
a were  assayed  by  cytotoxic  activity  on  L929  cells.  Each
value represents the mean ± SEM from five to seven animals.
*p < 0.05 compared with control.inflammation  results  in  increased  expression,  or
altered  avidity  of  adhesion  molecules,  and  thus
increases in the adhesiveness of both the circulating
cells and the endothelium.15
The  involvement  of  LECAM-1,  ICAM-1,  LFA-1,
PECAM-1  and  CD18  adhesion  molecules  in  the
leukocyte influx  into  the peritoneal cavity of mice
after injection of BjV was investigated by pre-treating
animals with selected anti-adhesion moleculemAbs.
Previous  results  from  our  laboratory showed a  sig-
nificant accumulation of PMN cells into the peritoneal
cavity of mice up to 24h following BjV injection, with
maximal counts of neutrophils between 3 and 12h.3
Present data showed that the anti-mouse LECAM-
1mAb significantly reduced the neutrophil migration.
LECAM-1  is  constitutively  expressed  on  the  neu-
trophil  and  is  shed  from  the  cell  surface  on  cell
activation, contributing  to neutrophil rolling  at the
initial  phase  of  the  adhesion  cascade.21 Thus,  the
obtained data suggest that BjV induces the expression
of this leukocyte adhesion molecule from the selectin
family that mediates rolling events. Previous reports
have shown that L-selectin participates in leukocyte
rolling after tissue trauma.22
The expression of selectin adhesion molecules in
leukocytes  does  not  lead  to  firm  adhesion  and
transmigration unless another set of adhesion mole-
cules  is  engaged.  For  neutrophils,  firm  adhesion
requires activation of the b2(CD18) adhesion molecule
from the integrin family, resulting in binding to one of
the intercellular adhesion molecules at the surfaces of
endothelial  cells.23 Results  showed  that  anti-mouse
LFA-1 (CD11a/CD18)mAb strongly inhibited the cell
influx in our model.  This further indicates the ability of
the BjV to activate neutrophils to express adhesion
molecules, in this case an integrin that is relevant for
the  firm  adhesion  of  leukocytes.  Conversely,  no
inhibitory  effect  of  anti-CD18mAb  on  neutrophil
migration  was  observed. This  result  is  unexpected
because  the  literature  shows  that  blockingmAbs
directed  against  CD18  are  effective  inhibitors  of
neutrophil migration in various inflammatory models
in vivo.15 However, CD18-independent mechanisms
of cell adhesion are also known to exist24,25 and it is
well  established  that  CD18-independent  neutrophil
migration  occurs  in  pulmonary  inflammation  in
numerous animal species.26,27 In addition, Winn and
Harlan28 have  described  a  CD18-independent  neu-
trophil migration into the peritoneum of rabbits due to
release of a factor by macrophage already present at
the inflammatory site. However, we cannot discard the
contribution  of  CD18  on  BjV-induced  neutrophil
influx in other time intervals that were not evaluated in
this study. It is possible that, at the period of time used
to analyze the influx of neutrophils (6h), the increased
expression of other adhesion molecules could over-
come the blockade of CD18, a hypothesis that needs to
be further addressed.
In addition, we observed that venom-elicited peri-
toneal neutrophil influx was inhibited by both anti-
ICAM-1 and anti-PECAM-1mAbs. These results suggest
that ICAM-1 and PECAM-1 may be required  for  the
venom-induced trafficking of neutrophils and indicate
the ability of BjV to activate the endothelium, since
these molecules are expressed by endothelial cells.29
ICAMs are ligands  for  the  integrin  molecules  LFA-1
and  MAC-1  on  leukocytes.10 ICAM-1  participates in
leukocyte–leukocyte, leukocyte–endothelial, and leu-
kocyte–epithelial  cell  interations,  transendothelial
migration,  and  adhesion-dependent  respiratory
burst.30Thus, in the present experimental conditions,
ICAM-1  may  be  the  ligand  for  LFA-1  and  both
molecules may contribute to neutrophIL–endothelial
interactions.
PECAM-1 is one of the most abundant proteins on
the endothelial cell surface. It is located at the cell–
cell borders of adjacent endothelial cells and plays an
important role in transendothelial migration of neu-
trophils.31 PECAM-1 is  important in  the passage  of
neutrophils through endothelial junctions mainly in
cytokine-activated transmigration;  it  seems  to  have
little role in the chemotactic transmigration.13 Taking
into account that large accumulation of neutrophils
occurs at 6h, we suggest that the venom may trigger
a cytokine-activated transmigration process leading to
the  passage  of  neutrophils  across endothelium  and
into the tissues. Our results, however, do not rule out
the  possibility  that  a  chemotactic-dependent  or  a
PECAM-1-independent mechanism may  also operate
in the passage of leukocyte through the endothelial
cell  junctions  at  the  early  stages  of  inflammatory
response to the venom. To our knowledge this is the
first  report  dealing  with  characterization  of  the
adhesion molecules involved in the leukocyte influx
induced by snake venoms.
It is well  known that LTB4 and TXA2 induce the
expression of ICAM-1 and PECAM-1 adhesion mole-
cules.32,33To further analyze the inflammatory events
that could be involved in the expression of adhesion
molecules  secondary  to  venom  administration,  the
release of these eicosanoids into the peritoneal cavity
was analyzed. Results showed that i.p. injection of BjV
induced  a  significant  increment  in  intraperitoneal
concentrations of LTB4 and TXA2. These results are in
agreement with the previous observations showing
the release of eicosanoids into the air pouch injected
with BjV,6 as well as in the site of injection of venoms
from other species of Bothrops genus.4,34 Thus, our
observations suggest that these mediators may con-
tribute  to  the  expression  of  ICAM-1  and  PECAM-1
induced by  BjV. Alternatively, a direct effect of this
venom on the endothelium cannot be ruled out. On
the other hand, Farsky et al.6,35 showed that venoms
of Bothrops asper and Bothrops jararaca do not alter
the intrinsic mechanisms involved in leukocyte loco-
motion, in an experimental model in vitro.
Leukocyte recruitment induced by BjV
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tors responsible for up-regulation of the expression of
adhesion  molecules,36 and  they  participate  in  a
variety  of  inflammatory conditions.37 Among  them,
TNF-a,  IL-6  and  IL-1a are  highly  relevant.  Elevated
concentrations of TNF-a in the peritoneal cavity were
detected after i.p. injection of BjV. TNF-a induces the
expression  of  ICAM-1,  E-selectin38 and  CD11b/
CD18.39As a mediator of inflammation, it triggers the
release of practically all known mediators such as IL-1,
IL-6, IL-8 and all metabolites of arachidonic acid,40,41
thereby amplifying the inflammatory cascade. In our
experimental model, TNF-a may be relevant for the
expression of ICAM-1 thereby contributing for neu-
trophil influx. Moreover, release of TNF-a was a long-
lasting effect following BjV injection, which suggests
that  this  cytokine  may  be  also  important  in  the
activation of leukocytes and production of hydrogen
peroxide  and  nitric  oxide  observed  after  venom
injection.3
IL-6  is  also  likely  to  be  involved  in  leukocyte
infiltration induced by BjV. The i.p. injection of BjV
induced a significant increment in the concentration
of IL-6 in the peritoneal exudates. These results are in
concordance with others showing an increase of this
cytokine in the serum of mice after i.p. and subcuta-
neous  injection  of  snake  venoms  from  Bothrops
sp.42–44
IL-6 is related to the systemic acute phase response
associated  with  infection  or  injury,  including  the
release of neutrophils into the circulation and the up-
regulation of ICAM-1 expression.45 Thus, our results
suggest that IL-6 may have a role in the expression of
ICAM-1  following  BjV  injection,  being  relevant  for
firm adhesion of  neutrophils. Moreover, since max-
imal production of IL-6 occurs at 3h, a time when no
release of TNF-a was observed, IL-6 may also act as a
negative mediator of TNF-a production and/or secre-
tion in this experimental model, in agreement with
previous observations.44 On the other hand, levels of
IL-1a were not detectable in our experimental model,
in  contrast  with  previous  observations  describing
increments in IL-1 levels in serum of mice after i.p.
injection of BjV.44 It is likely that non-peritoneal cells
are responsible for the production of  IL-1  after i.p.
injection,  resulting  in  the  increments  described  in
serum.
Many cell types produce and secrete inflammatory
mediators  involved  in  the  leukocyte  influx  after
stimulation. In this way, monocytes and macrophages
are the central sources of the studied cytokines and
eicosanoids.40 Mast cells represent another source of
TNF-a and store this cytokine in specific granules.46
Taking  into  account  that  BjV  is  able  to  stimulate
macrophages and neutrophils,3 we assume that these
cells,  mainly  macrophages,  are  relevant  sources  of
eicosanoids and TNF-a in  our  experimental  model.
However,  the contribution  of  mast  cells  cannot be
ruled  out,  since  an  earlier  release  of  TNF-a was
detected in the local of BjV injection. Phospholipase
A2-homologues isolated from  Bothrops jararacussu
venom degranulate mast cells in rats.47
In conclusion, we have shown that the neutrophil
influx induced by i.p. injection of BjV venom in mice
is related to the expression of LECAM-1, LFA-1, ICAM-
1, and PECAM-1 adhesion molecules, responsible for
the rolling, firm adhesion and transmigration events
associated with neutrophil migration. This indicates
that the venom is able to induce the expression of
adhesion molecules from both leukocytes and endo-
thelial cells. This effect may be indirect, via the release
of eicosanoids LTB4 and TXA2, as well as the cytokines
TNF-a and IL-6, but not IL-1.
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